David E. Kaelin
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
- Organic Chemistry top 5%
- Synthetic Organic Chemistry Methods
- Carbohydrate Chemistry and Synthesis
- Asymmetric Synthesis and Catalysis
- Chemical synthesis and alkaloids
Papers in
-
- Synthetic Organic Chemistry Methods 6
- Asymmetric Synthesis and Catalysis 3
- Carbohydrate Chemistry and Synthesis 3
-
- Cancer therapeutics and mechanisms 4
- Chemical Synthesis and Analysis 3
- Co-authors
- Stephen F. Martin (8 shared papers)Omar D. Lopez (2 shared papers)I.M. Fellows (1 shared paper)B. Michael O’Keefe (2 shared papers)Douglas M. Mans (2 shared papers)Hilary R. Plake (1 shared paper)Steven M. Sparks (1 shared paper)Thomas A. Kirkland (1 shared paper)
- Journals
- Journal of the American Chemical Society (5 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Tetrahedron Letters (1 paper)MedChemComm (1 paper)Tetrahedron (1 paper)
- Partner nations
- United StatesChinaJapan
In The Last Decade
David E. Kaelin
14 papers receiving 497 citations
Peers
Comparison fields: 5 of 53
- Toxicology 50
- Organic Chemistry 408
- Pharmacology 130
- Molecular Medicine 32
- Biotechnology 41
Countries citing papers authored by David E. Kaelin
This map shows the geographic impact of David E. Kaelin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Kaelin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Kaelin more than expected).
Fields of papers citing papers by David E. Kaelin
This network shows the impact of papers produced by David E. Kaelin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Kaelin. The network helps show where David E. Kaelin may publish in the future.
Co-authors
The 25 scholars most cited alongside David E. Kaelin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 82 | |
| 2 | 2000 | 75 | |
| 3 | 2010 | 62 | |
| 4 | 2001 | 62 | |
| 5 | 2014 | 59 | |
| 6 | 2003 | 51 | |
| 7 | 2003 | 39 | |
| 8 | 2011 | 34 | |
| 9 | 2007 | 18 | |
| 10 | 2015 | 14 | |
| 11 | 2015 | 8 | |
| 12 | 2006 | 4 | |
| 13 | 2022 | 3 | |
| 14 | 2011 | 1 | |
| 15 | 2025 | 0 |
About David E. Kaelin
David E. Kaelin is a scholar working on Organic Chemistry, Molecular Biology, Pharmacology, Molecular Medicine and Toxicology, having authored 15 papers that have together received 512 indexed citations. Recurring topics across this work include Synthetic Organic Chemistry Methods (6 papers), Cancer therapeutics and mechanisms (4 papers), Antibiotic Resistance in Bacteria (4 papers), Asymmetric Synthesis and Catalysis (3 papers), Chemical Synthesis and Analysis (3 papers), Carbohydrate Chemistry and Synthesis (3 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). The work is most often cited by research in Toxicology (50 citations), Organic Chemistry (408 citations), Pharmacology (130 citations), Molecular Medicine (32 citations) and Biotechnology (41 citations). David E. Kaelin has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Stephen F. Martin, Omar D. Lopez, I.M. Fellows, B. Michael O’Keefe, Douglas M. Mans, Hilary R. Plake, Steven M. Sparks, Thomas A. Kirkland, John Colucci and Leo S. Geraci. Their work appears in journals such as Journal of the American Chemical Society, Bioorganic & Medicinal Chemistry Letters, Tetrahedron Letters, MedChemComm and Tetrahedron.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.